LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,497,028 | +53.0% | 65,146 | +6.9% | 0.01% | +25.0% |
| Q1 2023 | $2,938,527 | +107934.1% | 60,940 | +11.9% | 0.00% | 0.0% |
| Q4 2022 | $2,720 | -99.9% | 54,482 | +12.3% | 0.00% | +33.3% |
| Q3 2022 | $1,980,000 | -24.2% | 48,519 | +2.2% | 0.00% | -25.0% |
| Q2 2022 | $2,612,000 | +45.1% | 47,481 | -4.2% | 0.00% | +100.0% |
| Q1 2022 | $1,800,000 | -14.8% | 49,538 | +9.2% | 0.00% | 0.0% |
| Q4 2021 | $2,113,000 | – | 45,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |